Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TMS Co., Ltd. (4891:JPX), powered by AI.
TMS Co., Ltd. is currently trading at ¥120. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for TMS Co., Ltd. on Alpha Lenz.
View TMS Co., Ltd.'s valuation metrics on Alpha Lenz.
“TMS Co., Ltd.'s ROE is -21.1%. Explore profitability and growth together.”
Ask for details →TMS Co., Ltd. is a prominent entity in the pharmaceutical sector, renowned for its research and development prowess in medical treatments and healthcare solutions. The company focuses on creating innovative therapies and pharmaceutical products aimed at a wide range of medical conditions, playing a critical role in advancing health outcomes. TMS Co., Ltd.'s activities encompass the development and commercialization of both prescription and over-the-counter medications, contributing significantly to the healthcare and life sciences industries. Its operations not only highlight cutting-edge scientific research but also emphasize strategic partnerships and collaborations with global health organizations, enhancing its market presence. With headquarters in Tokyo, Japan, TMS Co., Ltd. serves diverse markets domestically and internationally, underlining its importance as a key player in medical innovation and patient care. This presence in the pharmaceutical industry underscores its commitment to addressing global health challenges through science-driven solutions.
“TMS Co., Ltd.'s ROE is -21.1%. Explore profitability and growth together.”
Ask for details →TMS Co., Ltd. (ticker: 4891) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 18 employees.
The current price is 120 with a P/E ratio of -x and P/B of -x.
ROE is -21.06%.